Antithrombin: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
No edit summary |
||
(23 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load='3evj' size='350' side='right' caption='Glycosylated human antithrombin III complex with heparin (in green) (PDB code [[3evj]])' scene='46/466527/Cv/1'> | |||
== Function == | |||
'''Antithrombin''' (AT) inactivates several enzymes of the coagulation cycle. AT is relatively inactive until it binds the heparan sidechains of the microvasculature.<ref>PMID:15311269</ref><br /> | |||
▪ '''α-AT''' contains 4 occupied glycosylation sites and is found in blood palsma.<br /> | |||
▪ '''β-AT''' contains only 3 occupied glycosylation sites.<br /> | |||
▪ '''AT-I''' refers to the absorption of thrombin to fibrin.<br /> | |||
▪ '''AT-II''' and heparin interfere with the interaction of thrombin and fibrinogen.<br /> | |||
▪ '''AT-III''' inactivates thrombin in plasma. For details see [[Student Projects for UMass Chemistry 423 Spring 2012-7|Student Projects for UMass Chemistry 423 Spring 2012-7 - Antithrombin III: Devourer of Memories]].<br /> | |||
▪ '''AT-IV''' becomes activated during blood coagulation.<br /> | |||
See details for the antithrombin pentasaccharide complex in [[Molecular Playground/Antithrombin-Heparin]]. | |||
== | == Disease == | ||
AT deficiency diseases are: Acquired AT deficiency and Inherited AT deficiency. AT deficiency is involved in thrombosis and pulmonary embolism. | |||
== Relevance == | |||
AT activity is enhanced upon <scene name='46/466527/Cv/4'>binding to the anticoagulant drug heparin</scene>. | |||
==Structural highlights== | |||
The binding of AT to the heparans or the heparin drug is to a core pentasaccharide. The binding induces conformational change of AT. | |||
==3D structures of antithrombin== | |||
[[Antithrombin 3D structures]] | |||
</StructureSection> | |||
== References == | |||
<references/> | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Latest revision as of 12:58, 25 December 2019
FunctionAntithrombin (AT) inactivates several enzymes of the coagulation cycle. AT is relatively inactive until it binds the heparan sidechains of the microvasculature.[1] ▪ α-AT contains 4 occupied glycosylation sites and is found in blood palsma. DiseaseAT deficiency diseases are: Acquired AT deficiency and Inherited AT deficiency. AT deficiency is involved in thrombosis and pulmonary embolism. RelevanceAT activity is enhanced upon . Structural highlightsThe binding of AT to the heparans or the heparin drug is to a core pentasaccharide. The binding induces conformational change of AT. 3D structures of antithrombin
|
|
ReferencesReferences
- ↑ Li W, Johnson DJ, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol. 2004 Sep;11(9):857-62. Epub 2004 Aug 15. PMID:15311269 doi:10.1038/nsmb811